|
⚲
|
| Keyboard |
| Kraus Carl N
✚
|
|
|---|---|
| CIK # | 0001946475 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001946475] | |
| 4 | [0001946475] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kraus Carl N | |
| Aquestive Therapeutics Inc | |
| Idera Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2025-10-15 | Sell | 20,272 | $7.00 | 141,904 |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2025-08-09 | Tax withheld | 10,819 | $3.90 | 42,194 |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2025-03-07 | Grant | 70,000 | $0.00 | |
|
Aquestive Therapeutics Inc AQST
Non-Qualified Stock Option (right to buy) · derivative
|
2025-03-07 | Grant | 30,000 | $0.00 | |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2025-03-07 | Tax withheld | 8,115 | $2.65 | 21,505 |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2024-08-09 | Tax withheld | 10,819 | $3.43 | 37,109 |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2024-03-07 | Grant | 112,500 | $0.00 | |
|
Aquestive Therapeutics Inc AQST
Non-Qualified Stock Option (right to buy) · derivative
|
2024-03-07 | Grant | 56,250 | $0.00 | |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2023-08-09 | Grant | 150,000 | $0.00 | |
|
Idera Pharmaceuticals Inc ACGN
Stock Options (Right ot Buy) · derivative
|
2023-01-20 | Grant | 25,400 | $0.00 | |
|
Idera Pharmaceuticals Inc ACGN
Options (Right to Buy) · derivative
|
2023-01-17 | Option exercise | 440,844 | ||
|
Idera Pharmaceuticals Inc IDRA
Options (Right to Buy) · derivative
|
2022-09-28 | Grant | 6,843 | ||
|
Idera Pharmaceuticals Inc IDRA
Series Z Preferred Stock · derivative
|
2022-09-28 | Grant | 6,843 | ||
|
Idera Pharmaceuticals Inc IDRA
Options (Right to Buy) · derivative
|
2022-09-28 | Grant | 651,364 |